Year-end Sale % OFF 
Abstract
Background: Recombinant human G-CSF hastens neutrophil recovery following hematopoietic stem cell transplantation (HSCT), thus accelerating engraftment.The optimal timing for use of G-CSF in conjunction to HSCT needs to be established.We present our data on effects of adding an extra dose of G-CSF (filgrastim 5 micro gm/kg) on day -1 of HSCT. Patients and Methods: Forty three consecutive patients who underwent HSCT in one year period were given G-CSF on day +1 (day before stem cell infusion) in addition to the regular doses from day +1 till engraftment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
